Search Results 301-310 of 17669 for Glucocorticoids

1. Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults - Mayo Clinic

   John's Wort, efavirenz, nevirapine, glucocorticoids (other than topical usage), modafinil, pioglitazone, and rifabutin 24. Evidence of cardiac disease ...

2. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   the last dose. 7. Chronic, systemically administered glucocorticoids in doses equivalent to >5 mg prednisone daily. Replacement corticosteroids for adrenal ...

3. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

   If receiving glucocorticoid treatment at screening, treatment must be tapered down and administered with a maximum of 10 mg daily in the last 14 days prior to ...

4. Publications - Juan Pablo Domecq Garces, M.D. - Mayo Clinic

   Ninan J, Nikravangolsefid N, Truong HH, Charkviani M, Prokop LJ, Murugan R, Clermont G, Kashani KB, Domecq Garces JP.

5. A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW) - Mayo Clinic

   Glucocorticoid therapy within the 14 days prior to randomization that exceeds a cumulative dose of 160 mg of dexamethasone or 1000 mg prednisone. Radiation ...

6. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

   If induction with glucocorticoidsalone, patient must have failed to attain remission after 3 months and the glucocorticoid dose must be ≥15 mg/day ...

7. Baricitinib In Relapsing Giant Cell Arteritis - Mayo Clinic

   ... glucocorticoid treatment such that they would not be able to safely undergone a standardized glucocorticoid taper. Participating Mayo Clinic locations. Study ...

8. A Study Of Alcohol Use In Alcohol-associated Liver Disease - Mayo Clinic

   Prior exposure to systemic corticosteroid (glucocorticoid) or immunosuppressive therapy for more than 2 days within the previous 30 days. Current use of ...

9. Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years - Mayo Clinic

   - Frequent, repeated use of oral or parenteral glucocorticoids (e.g., prednisone, prednisolone, dexamethasone). Steroid inhalers and topical steroids may be ...

10. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Glucocorticoids for any purpose other than to modulate symptoms from an adverse event of suspected immunologic etiology. Physiologic doses of ...